-
Mashup Score: 1Free Advanced Website for Reading Business Blogs of All Departments.NICE backs Alnylam’s Amvuttra for rare form of amyloidosis – - 1 year(s) ago
Alnylam’s gene-silencing drug Amvuttra has been recommended as a treatment for hereditary transthyretin-related (ATTR) amyloidosis by NICE, paving the way for the drug to be made available on the N…
Source: Business BlogCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Free Advanced Website for Reading Business Blogs of All Departments.Amvuttra recommended by NICE for amyloidosis - 1 year(s) ago
Therapy is among the first to receive a positive draft recommendation under streamlined pilot processAlnylam has welcomed a draft decision from the National Institute for Healt…
Source: Business BlogCategories: Hem/Oncs, Latest HeadlinesTweet
RT @mohammadali_im: #NICE #backs Alnylam’s #Amvuttra for #rare #form of #amyloidosis – https://t.co/jWxjjVL581+ #alnylams